• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ROCHE DIAGNOSTICS COBAS B 123 <4> SYSTEM; BLOOD GAS ANALYZER

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ROCHE DIAGNOSTICS COBAS B 123 <4> SYSTEM; BLOOD GAS ANALYZER Back to Search Results
Catalog Number 05122287001
Device Problem Incorrect Or Inadequate Test Results (2456)
Patient Problem No Consequences Or Impact To Patient (2199)
Event Date 07/26/2014
Event Type  malfunction  
Manufacturer Narrative
The laboratory method used for comparison was the siemens exl clinical chemistry analyzer.
 
Manufacturer Narrative
A specific root cause could not be determined.Additional information for investigation was requested, but not provided.No system related issues were found.A sample related issue is assumed to be the cause of the event.The sample measurement showed an extremely high thb and mchc values, which is indicative of the presence of micro-clots in the sample.Micro-clots can lead to a decrease or scattering of transmitted light during measurement, in turn, leading to an increased thb, however this could not be confirmed.
 
Event Description
The customer reported that they had been getting false positive bilirubin results from an unknown number of neonatal patient samples when compared to the laboratory method.The customer provided result data from 2 different patients.For these 2 patients, it was determined that erroneous results were reported for partial pressure of carbon dioxide at patient's temperature (pco2t), partial pressure of oxygen at patient's temperature (po2t), bicarbonate concentration in plasma (chco3-), base excess of blood (be), oxygen saturation (so2), bilirubin (bili), ion selective electrode (ise)potassium (k+), ise sodium (na+), ionized calcium (ca2+), glucose (glu), and lactate (lac).It was asked, but it is not known if same samples or different samples were used for repeat testing.All results from the analyzer were sent to the electronic health record of the affected patients and were given to the doctor.The results from the analyzer were not believed by the customer and only the results obtained using the laboratory method were used to assess if therapy was necessary.For patient one, eleven sets of replicate results from the analyzer were provided and can be seen on the attached sheet.Additional bilirubin results of 5.0 mg/dl for the analyzer method and 6.20 mg/dl for the laboratory method were provided from (b)(6) 2014.Additional bilirubin results of 13.7 mg/dl for the analyzer method and 12.10 mg/dl for the laboratory method were provided from (b)(6) 2014.Additional bilirubin results of 18.5 mg/dl for the analyzer method and 11.80 mg/dl for the laboratory method were provided from (b)(6) 2014.Additional bilirubin results of 12.6 mg/dl for the analyzer method and 14.93 mg/dl for the laboratory method were provided from (b)(6) 2014.It was asked, but it is unknown if these additional analyzer results were duplicates of any information on the attachment.Patient one also had bilirubin results of 5.70 mg/dl on (b)(6) 2014, 10.80 mg/dl on (b)(6) 2014, 16.30 mg/dl on (b)(6) 2014, 14.20 mg/dl on (b)(6) 2014, and 14.20 mg/dl on (b)(6) 2014 using the laboratory method.Patient two had a result of 20.5 mg/dl for bilirubin on the analyzer and a result of 16.7 mg/dl for bilirubin using the laboratory method.The patients were not adversely affected.Reagent and electrode lot numbers and expiration dates for the involved tests were asked for, but not provided.
 
Manufacturer Narrative
This event occurred in (b)(6).
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
COBAS B 123 <4> SYSTEM
Type of Device
BLOOD GAS ANALYZER
Manufacturer (Section D)
ROCHE DIAGNOSTICS
9115 hague road
indianapolis IN 46250
Manufacturer (Section G)
ROCHE INSTRUMENT CENTER AG TEGIMENTA
forrenstrasse
na
rotkreuz 6343
SZ   6343
Manufacturer Contact
michael leslie
9115 hague road
na
indianapolis, IN 46250
3175214343
MDR Report Key4059907
MDR Text Key12604961
Report Number1823260-2014-06785
Device Sequence Number1
Product Code CHL
Combination Product (y/n)N
Reporter Country CodeGM
PMA/PMN Number
K111188
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Foreign,Health Professional,User Facility
Reporter Occupation Health Professional
Type of Report Initial,Followup,Followup
Report Date 11/17/2014
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received09/04/2014
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Nurse
Device Catalogue Number05122287001
Was Device Available for Evaluation? Yes
Is the Reporter a Health Professional? Yes
Event Location Laboratory
Date Manufacturer Received08/11/2014
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? No
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Treatment
AMPICILLIN 3 TIMES DAILY (PATIENT ONE); NYSTATIN 3 TIMES DAILY (PATIENT ONE); CEFOTAXIM 3 TIMES DAILY (PATIENT ONE)
Patient Age001 DA
Patient Weight3
-
-